Israel Insulin Biosimilars Market (2025-2031) | Analysis, Share, Outlook, Value, Competitive Landscape, Companies, Industry, Growth, Trends, Size & Revenue, Forecast, Segmentation

Name: Israel Insulin Biosimilars Market (2025-2031) | Analysis & Share
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy
Keywords: Insulin Biosimilars Market, Israel Insulin Biosimilars Market, Israel Insulin Biosimilars Market Revenues, Israel Insulin Biosimilars Market Share, Israel Insulin Biosimilars Market Size, Israel Insulin Biosimilars Market Outlook, Israel Insulin Biosimilars Market Report, Israel Insulin Biosimilars Market Competition, Israel Insulin Biosimilars Market Overview, Israel Insulin Biosimilars Market Trends, Israel Insulin Biosimilars Market Forecast

Market Forecast By Product Type (Rapid-acting biosimilar, Long-acting biosimilar, Premixed biosimilar), By Indicative (Type I Diabetes, Type II Diabetes), By End User (Hospitals, Ambulatory Surgical Centers, Others) And Competitive Landscape

Product Code: ETC7653889	Publication Date: Sep 2024	Updated Date: Nov 2025	Product Type: Market Research Report
Publisher: 6Wresearch	Author: Vasudha	No. of Pages: 75	No. of Figures: 35	No. of Tables: 20

Israel Insulin Biosimilars Market Top 5 Importing Countries and Market Competition (HHI) Analysis

The import shipments of insulin biosimilars into Israel in 2024 saw significant contributions from top exporting countries such as Switzerland, USA, Germany, China, and Belgium. Despite a negative CAGR from 2020 to 2024, the market showed growth in 2024 with a notable 8.63% increase from the previous year. The High Herfindahl-Hirschman Index (HHI) in 2024 indicates a market with very high concentration, highlighting the dominance of key players in the insulin biosimilars sector in Israel.

Israel Insulin Biosimilars Market Top 5 Importing Countries and Market Competition (HHI) Analysis

Key Highlights of the Report:

Israel Insulin Biosimilars Market Outlook
Market Size of Israel Insulin Biosimilars Market, 2024
Forecast of Israel Insulin Biosimilars Market, 2031
Historical Data and Forecast of Israel Insulin Biosimilars Revenues & Volume for the Period 2021- 2031
Israel Insulin Biosimilars Market Trend Evolution
Israel Insulin Biosimilars Market Drivers and Challenges
Israel Insulin Biosimilars Price Trends
Israel Insulin Biosimilars Porter's Five Forces
Israel Insulin Biosimilars Industry Life Cycle
Historical Data and Forecast of Israel Insulin Biosimilars Market Revenues & Volume By Product Type for the Period 2021- 2031
Historical Data and Forecast of Israel Insulin Biosimilars Market Revenues & Volume By Rapid-acting biosimilar for the Period 2021- 2031
Historical Data and Forecast of Israel Insulin Biosimilars Market Revenues & Volume By Long-acting biosimilar for the Period 2021- 2031
Historical Data and Forecast of Israel Insulin Biosimilars Market Revenues & Volume By Premixed biosimilar for the Period 2021- 2031
Historical Data and Forecast of Israel Insulin Biosimilars Market Revenues & Volume By Indicative for the Period 2021- 2031
Historical Data and Forecast of Israel Insulin Biosimilars Market Revenues & Volume By Type I Diabetes for the Period 2021- 2031
Historical Data and Forecast of Israel Insulin Biosimilars Market Revenues & Volume By Type II Diabetes for the Period 2021- 2031
Historical Data and Forecast of Israel Insulin Biosimilars Market Revenues & Volume By End User for the Period 2021- 2031
Historical Data and Forecast of Israel Insulin Biosimilars Market Revenues & Volume By Hospitals for the Period 2021- 2031
Historical Data and Forecast of Israel Insulin Biosimilars Market Revenues & Volume By Ambulatory Surgical Centers for the Period 2021- 2031
Historical Data and Forecast of Israel Insulin Biosimilars Market Revenues & Volume By Others for the Period 2021- 2031
Israel Insulin Biosimilars Import Export Trade Statistics
Market Opportunity Assessment By Product Type
Market Opportunity Assessment By Indicative
Market Opportunity Assessment By End User
Israel Insulin Biosimilars Top Companies Market Share
Israel Insulin Biosimilars Competitive Benchmarking By Technical and Operational Parameters
Israel Insulin Biosimilars Company Profiles
Israel Insulin Biosimilars Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 Israel Insulin Biosimilars Market Overview

3.1 Israel Country Macro Economic Indicators

3.2 Israel Insulin Biosimilars Market Revenues & Volume, 2021 & 2031F

3.3 Israel Insulin Biosimilars Market - Industry Life Cycle

3.4 Israel Insulin Biosimilars Market - Porter's Five Forces

3.5 Israel Insulin Biosimilars Market Revenues & Volume Share, By Product Type, 2021 & 2031F

3.6 Israel Insulin Biosimilars Market Revenues & Volume Share, By Indicative, 2021 & 2031F

3.7 Israel Insulin Biosimilars Market Revenues & Volume Share, By End User, 2021 & 2031F

4 Israel Insulin Biosimilars Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.3 Market Restraints

5 Israel Insulin Biosimilars Market Trends

6 Israel Insulin Biosimilars Market, By Types

6.1 Israel Insulin Biosimilars Market, By Product Type

6.1.1 Overview and Analysis

6.1.2 Israel Insulin Biosimilars Market Revenues & Volume, By Product Type, 2021- 2031F

6.1.3 Israel Insulin Biosimilars Market Revenues & Volume, By Rapid-acting biosimilar, 2021- 2031F

6.1.4 Israel Insulin Biosimilars Market Revenues & Volume, By Long-acting biosimilar, 2021- 2031F

6.1.5 Israel Insulin Biosimilars Market Revenues & Volume, By Premixed biosimilar, 2021- 2031F

6.2 Israel Insulin Biosimilars Market, By Indicative

6.2.1 Overview and Analysis

6.2.2 Israel Insulin Biosimilars Market Revenues & Volume, By Type I Diabetes, 2021- 2031F

6.2.3 Israel Insulin Biosimilars Market Revenues & Volume, By Type II Diabetes, 2021- 2031F

6.3 Israel Insulin Biosimilars Market, By End User

6.3.1 Overview and Analysis

6.3.2 Israel Insulin Biosimilars Market Revenues & Volume, By Hospitals, 2021- 2031F

6.3.3 Israel Insulin Biosimilars Market Revenues & Volume, By Ambulatory Surgical Centers, 2021- 2031F

6.3.4 Israel Insulin Biosimilars Market Revenues & Volume, By Others, 2021- 2031F

7 Israel Insulin Biosimilars Market Import-Export Trade Statistics

7.1 Israel Insulin Biosimilars Market Export to Major Countries

7.2 Israel Insulin Biosimilars Market Imports from Major Countries

8 Israel Insulin Biosimilars Market Key Performance Indicators

9 Israel Insulin Biosimilars Market - Opportunity Assessment

9.1 Israel Insulin Biosimilars Market Opportunity Assessment, By Product Type, 2021 & 2031F

9.2 Israel Insulin Biosimilars Market Opportunity Assessment, By Indicative, 2021 & 2031F

9.3 Israel Insulin Biosimilars Market Opportunity Assessment, By End User, 2021 & 2031F

10 Israel Insulin Biosimilars Market - Competitive Landscape

10.1 Israel Insulin Biosimilars Market Revenue Share, By Companies, 2024

10.2 Israel Insulin Biosimilars Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Africa Insulin Biosimilars Market

Global Insulin Biosimilars Market

Middle East Insulin Biosimilars Market

North America Insulin Biosimilars Market

Uruguay Insulin Biosimilars Market

Uzbekistan Insulin Biosimilars Market

Vanuatu Insulin Biosimilars Market

Yemen Insulin Biosimilars Market

Zambia Insulin Biosimilars Market

Export potential assessment - trade Analytics for 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here